These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 26975224

  • 21. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
    Tanawuttiwat T, Garisto JD, Salow A, Glad JM, Szymkiewicz S, Saltzman HE, Kutalek SP, Carrillo RG.
    Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055
    [Abstract] [Full Text] [Related]

  • 22. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
    Ellenbogen KA, Koneru JN, Sharma PS, Deshpande S, Wan C, Szymkiewicz SJ.
    JACC Clin Electrophysiol; 2017 Mar; 3(3):243-250. PubMed ID: 29759518
    [Abstract] [Full Text] [Related]

  • 23. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
    Skowasch D, Ringquist S, Nickenig G, Andrié R.
    PLoS One; 2018 Mar; 13(3):e0194496. PubMed ID: 29566033
    [Abstract] [Full Text] [Related]

  • 24. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator.
    Goldenberg I, Erath JW, Russo AM, Burch AE, Assmus B, Bonderman D, McNitt S, Kutyifa V.
    Heart Rhythm; 2021 Mar; 18(3):404-410. PubMed ID: 33248269
    [Abstract] [Full Text] [Related]

  • 25. Use of the wearable external cardiac defibrillator in children.
    Everitt MD, Saarel EV.
    Pacing Clin Electrophysiol; 2010 Jun 01; 33(6):742-6. PubMed ID: 20202137
    [Abstract] [Full Text] [Related]

  • 26. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU, Goldenberg I, Moss AJ.
    Eur Heart J; 2013 Aug 01; 34(29):2230-42. PubMed ID: 23729691
    [Abstract] [Full Text] [Related]

  • 27. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital.
    Sinha AM, Bense J, Hohenforst-Schmidt W.
    J Interv Card Electrophysiol; 2021 Nov 01; 62(2):401-407. PubMed ID: 33200285
    [Abstract] [Full Text] [Related]

  • 28. Use of the wearable cardioverter-defibrillator - the Swiss experience.
    Kovacs B, Reek S, Sticherling C, Schaer B, Linka A, Ammann P, Brenner R, Krasniqi N, Müller AS, Dzemali O, Kobza R, Grebmer C, Haegeli L, Berg J, Mayer K, Schläpfer J, Domenichini G, Reichlin T, Roten L, Burri H, Eriksson U, Saguner AM, Steffel J, Duru F, Swiss Wcd Registry.
    Swiss Med Wkly; 2020 Sep 21; 150():w20343. PubMed ID: 33035354
    [Abstract] [Full Text] [Related]

  • 29. Ventricular Arrhythmia Occurrence and Compliance in Patients Treated With the Wearable Cardioverter Defibrillator Following Percutaneous Coronary Intervention.
    Barraud J, Pinon P, Laine M, Cautela J, Orabona M, Koutbi L, Pinto J, Thuny F, Franceschi F, Paganelli F, Bonello L, Peyrol M.
    Heart Lung Circ; 2018 Aug 21; 27(8):984-988. PubMed ID: 28969980
    [Abstract] [Full Text] [Related]

  • 30. Wearable Cardioverter Defibrillators.
    Ferrick AM, Tian D, Vudathaneni V, Shevchuk OL, Ferrick NJ, Frishman W.
    Cardiol Rev; 2016 Aug 21; 24(6):282-287. PubMed ID: 27548691
    [Abstract] [Full Text] [Related]

  • 31. Study of the wearable cardioverter defibrillator in advanced heart-failure patients (SWIFT).
    Barsheshet A, Kutyifa V, Vamvouris T, Moss AJ, Biton Y, Chen L, Storozynsky E, Wan C, Szymkiewicz SJ, Goldenberg I.
    J Cardiovasc Electrophysiol; 2017 Jul 21; 28(7):778-784. PubMed ID: 28429542
    [Abstract] [Full Text] [Related]

  • 32. Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death.
    Elbayomi M, Weyand M, Seitz T, Harig F.
    Ann Noninvasive Electrocardiol; 2023 Mar 21; 28(2):e13048. PubMed ID: 36723848
    [Abstract] [Full Text] [Related]

  • 33. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD).
    Klein HU, Meltendorf U, Reek S, Smid J, Kuss S, Cygankiewicz I, Jons C, Szymkiewicz S, Buhtz F, Wollbrueck A, Zareba W, Moss AJ.
    Pacing Clin Electrophysiol; 2010 Mar 21; 33(3):353-67. PubMed ID: 19889186
    [Abstract] [Full Text] [Related]

  • 34. The use of wearable cardioverter-defibrillators in Europe: results of the European Heart Rhythm Association survey.
    Lenarczyk R, Potpara TS, Haugaa KH, Hernández-Madrid A, Sciaraffia E, Dagres N, Scientific Initiatives Committee, European Heart Rhythm Association.
    Europace; 2016 Jan 21; 18(1):146-50. PubMed ID: 26842735
    [Abstract] [Full Text] [Related]

  • 35. Wearable Cardioverter-Defibrillators following Cardiac Surgery-A Single-Center Experience.
    Heimeshoff J, Merz C, Ricklefs M, Kirchhoff F, Haverich A, Bara C, Kühn C.
    Thorac Cardiovasc Surg; 2019 Mar 21; 67(2):92-97. PubMed ID: 29925094
    [Abstract] [Full Text] [Related]

  • 36. Age differences of patients treated with wearable cardioverter defibrillator: Data from a multicentre registry.
    El-Battrawy I, Tenbrink D, Kovacs B, Dreher TC, Blockhaus C, Klein N, Shin DI, Hijazi M, Rosenkaimer S, Beiert T, Abumayyaleh M, Saguner AM, Kowitz J, Erath JW, Duru F, Mügge A, Aweimer A, Akin I.
    Eur J Clin Invest; 2023 Jul 21; 53(7):e13977. PubMed ID: 36852491
    [Abstract] [Full Text] [Related]

  • 37. Use of the Wearable Cardioverter-Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry.
    El-Battrawy I, Koepsel K, Tenbrink D, Kovacs B, Dreher TC, Blockhaus C, Gotzmann M, Klein N, Kuntz T, Shin DI, Lapp H, Rosenkaimer S, Abumayyaleh M, Hamdani N, Saguner AM, Kowitz J, Erath JW, Duru F, Mügge A, Akin I, Aweimer A, Beiert T.
    J Am Heart Assoc; 2023 Sep 19; 12(18):e030615. PubMed ID: 37681569
    [Abstract] [Full Text] [Related]

  • 38. Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a case report.
    Andresen H, Sasko B, Patschan D, Pagonas N, Ritter O.
    J Med Case Rep; 2021 May 17; 15(1):243. PubMed ID: 33993888
    [Abstract] [Full Text] [Related]

  • 39. Outcome of Patients With In-Hospital Ventricular Tachycardia and Ventricular Fibrillation Arrest While Using a Wearable Cardioverter Defibrillator.
    Ellenbogen KA, Wan C, Shavelle DM.
    Am J Cardiol; 2018 Jan 15; 121(2):205-209. PubMed ID: 29153771
    [Abstract] [Full Text] [Related]

  • 40. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator.
    Duncker D, Haghikia A, König T, Hohmann S, Gutleben KJ, Westenfeld R, Oswald H, Klein H, Bauersachs J, Hilfiker-Kleiner D, Veltmann C.
    Eur J Heart Fail; 2014 Dec 15; 16(12):1331-6. PubMed ID: 25371320
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.